Received: 16 January 2022
Accepted: 26 February 2022
First Online: 5 March 2022
: The survey was approved by the Ethics Committee (Comité d’Ethique) Hospitalo-Facultaire des Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
: Not applicable.
: PP, LH, EVN and EP are scientific board members of, and have received consultancy fees from, IBSA Biochimique. IBSA has had no role in the design of the survey, data analyses, data presentation and interpretation, or writing of the manuscript.